Form 8-K · Current Report · Filed 2025-10-31
Metsera, Inc. Responds to Pfizer Litigation and Announces Proposed Acquisition
On October 31, 2025, Metsera, Inc. issued a statement in response to litigation filed by Pfizer Inc. Metsera disagrees with Pfizer's allegations and plans to address them in court. Additionally, the company disclosed Pfizer's proposed acquisition, which involves several risks and uncertainties, including regulatory approvals and potential integration challenges.
- Filer
- MTSR MTSR
- Filed
- Accession
- 0001193125-25-261203
- CIK
- 0002040807
- Signal
- Medium impact
- Source
- Official filing on sec.gov ↗
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$63.73
Next session
-4.7%
Since filing
+10.6%
Latest close
$70.50
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MTSR reporting the same item, with the next session's move:
Never miss another MTSR filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.